Lv1
100 积分 2023-03-10 加入
Blockade of interleukin-13 signalling improves skin barrier function and biology in patients with moderate-to-severe atopic dermatitis
24天前
已完结
Real-world experience of tralokinumab for atopic dermatitis in adults and adolescents: A 16-week multicenter retrospective study
24天前
已关闭
Clinical Outcomes of Tralokinumab and Lebrikizumab in Japanese Atopic Dermatitis Patients With Persistent Head and Neck Dermatitis After Long-Term Treatment With Dupilumab: A Single-Center Retrospective Study
24天前
已完结
Maintenance of Early Responses and Delayed Responses to Tralokinumab Treatment in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study
26天前
已关闭
Identifying Week 48 Delayed Responders to Tralokinumab in Real-World Practice for Japanese Patients with Moderate-to-Severe Atopic Dermatitis
26天前
已完结
Efficacy and drug survival of tralokinumab in patients with severe atopic dermatitis: an 18-month multicentre study
28天前
已完结
A 48-week real-world outcome of tralokinumab treatment for atopic dermatitis: Systemic therapy-naïve versus systemic therapy-experienced patients
1个月前
已完结
皖公网安备34019202002308
